Nano-suspension of difficult-to-dissolve medicine as well as preparation method and application of nano-suspension
A technology for insoluble drugs and nanosuspensions, which is applied in the direction of pharmaceutical formulations, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., and can solve the problems of sedimentation, short storage time, and particle aggregation of nanosuspensions and other issues to achieve the effect of improving stability and extending storage time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0030] The nanosuspension of insoluble drug in this embodiment is composed of the following components: 10 parts of stabilizer, 40 parts of insoluble drug particles, and the rest is water;
[0031] Poorly soluble drugs include azithromycin, baicalin, sirolimus, valsartan, and resveratrol;
[0032] The stabilizer includes a nonionic stabilizer and an ionic stabilizer, and the stabilizer includes a nonionic stabilizer and an ionic stabilizer in a mass ratio of 2-5:1;
[0033] The mass ratio of described nonionic stabilizer and ionic stabilizer is 3:1;
[0034] Described nonionic stabilizer is made of polyethylene glycol 200, Tween 20 and Span 80, and the mass ratio of polyethylene glycol 200, Tween 40 and Span 80 is 1:1:1;
[0035] Described ionic stabilizer is made of sodium lauryl sulfate and cetyl trimethyl quaternary ammonium salt, and the mass ratio of sodium lauryl sulfate and cetyl trimethyl quaternary ammonium salt is 4:1 .
[0036] A preparation method corresponding ...
Embodiment 2
[0042] The invention provides a nanosuspension of insoluble drugs, which is composed of the following components: 15 parts of a stabilizer, 50 parts of insoluble drug particles, and the rest is water;
[0043] Poorly soluble drugs include azithromycin, baicalin, sirolimus, valsartan, and resveratrol;
[0044] Described stabilizing agent comprises nonionic stabilizing agent and ionic stabilizing agent, and the mass ratio of nonionic stabilizing agent and ionic stabilizing agent is 5:1;
[0045] The mass ratio of described stabilizing agent including non-ionic stabilizing agent and ionic stabilizing agent is 5:1;
[0046] Described nonionic stabilizer is made of polyethylene glycol 200, Tween 20 and Span 80, and the mass ratio of polyethylene glycol 200, Tween 40 and Span 80 is 3:1:1;
[0047] The ionic stabilizer is composed of sodium lauryl sulfate and cetyl trimethyl quaternary ammonium salt, and the mass ratio of sodium lauryl sulfate and cetyl trimethyl quaternary ammonium...
Embodiment 3
[0050] On the basis of Example 1, the concentration of the insoluble drug particles is 6-8%, preferably 8%, which cooperates with nonionic surfactants and ionic surfactants to further improve the concentration of drug particles in suspension. stability in liquid.
[0051] The preparation method of the nanosuspension of the poorly soluble drug in Example 3 is the same as that in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com